Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 23, 2024Journal of Oncology Pharmacy Practice

Impact of pharmacist managed oral epidermal growth factor receptor inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

SNShirley NgKaiser PermanenteNBNicholas BakerKaiser PermanenteFNFang NiuMedtronic (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ng et al. (2024) studied this question.

synapsesocial.com/papers/68e5f630b6db64358758aadbhttps://doi.org/10.1177/10781552241265891
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic Databases2013 · 495 citations
  2. 2The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents2021 · 113 citations
  3. 3Supportive Care Treatments for Toxicities of Anti-EGFR and Other Targeted Agents2012 · 39 citations
  4. 4egfr Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions2012 · 3 citations
  5. 5Adherence, exposure and patients’ experiences with the use of erlotinib in non-small cell lung cancer2015 · 43 citations